Next Article in Journal
Diagnosis and Management of Progressive Multiple Sclerosis
Previous Article in Journal
Management of Bleeding from Unresectable Gastric Cancer
Open AccessReview

A Mini-Review: Clinical Development and Potential of Aptamers for Thrombotic Events Treatment and Monitoring

Department of Pharmaceutical Sciences, Nesbitt School of Pharmacy, Wilkes University, 84 W. South Street, Wilkes-Barre, PA 18766, USA
*
Author to whom correspondence should be addressed.
Biomedicines 2019, 7(3), 55; https://doi.org/10.3390/biomedicines7030055
Received: 29 June 2019 / Revised: 21 July 2019 / Accepted: 24 July 2019 / Published: 26 July 2019
(This article belongs to the Special Issue Engineering Aptamers for Biomedical Applications II)
The unique opportunity for aptamer uses in thrombotic events has sparked a considerable amount of research in the area. The short half-lives of unmodified aptamers in vivo remain one of the major challenges in therapeutic aptamers. Much of the incremental successful therapeutic aptamer stories were due to modifications in the aptamer bases. This mini-review briefly summarizes the successes and challenges in the clinical development of aptamers for thrombotic events, and highlights some of the most recent developments in using aptamers for anticoagulation monitoring. View Full-Text
Keywords: thrombotic event; aptamer; DNA; RNA; SELEX; molecular recognition element (MRE); monitoring; treatment thrombotic event; aptamer; DNA; RNA; SELEX; molecular recognition element (MRE); monitoring; treatment
Show Figures

Figure 1

MDPI and ACS Style

Ponce, A.T.; Hong, K.L. A Mini-Review: Clinical Development and Potential of Aptamers for Thrombotic Events Treatment and Monitoring. Biomedicines 2019, 7, 55.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop